James Perry
Hematology & Oncology · Philadelphia, PANPI 1710092135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $591 and has fallen 97.1% since, to $17 in 2023. That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
Across 41 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$216
- Beigene USA, Inc.$110
- Mckesson Specialty Care Distribution, LLC$100
- Pharmacyclics LLC, An Abbvie Company$69
- Amgen$56
- Novartis$52
- plus $356 from 16 others
What the payments were for
- Food & beverage$959100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 6 | $216 |
| Beigene USA, Inc. | 1 | $110 |
| Mckesson Specialty Care Distribution, LLC | 1 | $100 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $69 |
| Amgen | 3 | $56 |
| Novartis | 3 | $52 |
| Astellas Pharma US Inc | 3 | $46 |
| Bristol Myers Squibb | 2 | $39 |
| Tesaro, Inc. | 2 | $35 |
| Sanofi | 2 | $33 |
| Lilly USA, LLC | 2 | $29 |
| AstraZeneca(2 entities) | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Bayer | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| EMD Serono, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Foundation Medicine, Inc. | 1 | $13 |
| Taiho Oncology, Inc. | 1 | $12 |
| Seagen Inc. | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRUKINSA$110
How this compares
$959 in reported general payments places this provider in the 40th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Philadelphia
- Henry FungPhiladelphia$730K
- Charu AggarwalPhiladelphia$541K
- Corey LangerPhiladelphia$492K
- Ankur ParikhPhiladelphia$329K
- Catherine LaiPhiladelphia$281K
- Stephen SchusterPhiladelphia$218K
- Keith PratzPhiladelphia$173K
- David PorterPhiladelphia$140K
- Adam BinderPhiladelphia$136K
- Marcela MausPhiladelphia$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.